Tobacco and Nicotine
Ancient plant medicine, nicotinic receptors, controlled preparations, and emerging health research
For thousands of years, Indigenous peoples of the Americas cultivated tobacco as a sacred plant, healing ally, ceremonial offering, source of strength, and bridge between physical and spiritual life.
It was offered in prayer, carried in medicine bundles, placed upon the earth, incorporated into purification and ceremony, applied to the body, and prepared by knowledgeable healers for physical, emotional, mental, and spiritual purposes.
Long before modern laboratories identified nicotine or mapped nicotinic acetylcholine receptors, people were observing what tobacco did within the human body and within the larger relationship between plant, person, community, and spirit.
Modern science has opened another remarkable chapter.
Researchers now understand that tobacco contains a complex collection of biologically active compounds. Nicotine is only one of them. Nicotine itself interacts with an extensive receptor system already present throughout the human body, including pathways connected with the brain, nervous system, muscles, immune communication, digestion, inflammation, sensory processing, attention, and autonomic function.
Nicotine gum and nicotine patches represent another part of this evolving medicinal story. Rather than using the whole plant, they provide measured amounts of one naturally occurring tobacco alkaloid through controlled preparations.
Tobacco-family plants have also entered biotechnology laboratories, where their living cells can manufacture sophisticated proteins, antibodies, vaccine components, and experimental medicines.
The complete story of tobacco therefore reaches far beyond a single compound.
It stretches from ancient healing traditions to receptor biology, from centuries-old medical literature to modern neuroscience, and from plant chemistry to personalized biotechnology.
Focus of This Discussion
This information concerns:
The tobacco plant
Nicotiana tabacum
Nicotiana rustica
Traditional and ceremonial tobacco practices
Whole-leaf and plant preparations
Naturally occurring tobacco compounds
Nicotinic acetylcholine receptors
Nicotine gum
Nicotine patches
Medicinal nicotine research
Tobacco-derived cancer compounds
Nicotinic receptors as cancer targets
Tobacco plants used to produce cancer medicines
This discussion is focused on the tobacco plant, traditional preparations, nicotine gum, nicotine patches, and the medical, scientific, and biotechnological research connected with them.
Tobacco’s Ancient Place in Human Life
Tobacco originated in the Americas, where Indigenous peoples cultivated and worked with it long before European arrival.
There was never one universal Indigenous tobacco tradition.
Different peoples worked with different species and developed their own preparations, ceremonies, responsibilities, boundaries, and teachings concerning when tobacco was appropriate, how it should be prepared, who carried knowledge about it, and how its strength should be respected.
Traditional practices have included tobacco offered in prayer, carried in medicine bundles, placed upon the earth or water, used ceremonially, shared through ceremonial pipes, prepared as powders, applied externally, combined with other medicinal plants, and incorporated into specialist-guided healing and cleansing practices.
Historical medical literature later described tobacco preparations for wounds, sores, burns, toothache, rheumatic discomfort, digestive concerns, intestinal worms, respiratory complaints, fatigue, fainting, pain, and other conditions.
When tobacco reached Europe, physicians, herbalists, apothecaries, and botanical writers began incorporating it into the medicine of their own period.
Those older records remain valuable because they preserve what people observed, how preparations were used, and which biological effects appeared important enough to be recorded repeatedly.
Older medical literature is part of the research trail.
Sacred Tobacco and Prayer
For many Indigenous peoples, tobacco has never been understood merely as something placed into the body.
It may serve as an offering.
It may accompany prayer.
Tobacco may be offered before gathering medicinal plants, requesting knowledge, entering ceremony, making an agreement, expressing gratitude, asking for protection, or praying for healing.
Smoke rising upward may carry spiritual meaning involving gratitude, intention, prayer, and communication with the Creator.
Tobacco's strength was one reason many traditional systems surrounded it with knowledge, responsibility, preparation, and restraint.
Its history is therefore also a history of relationship.
Relationship with the plant.
Relationship with the healer.
Relationship with the earth.
Relationship with community.
Relationship with prayer.
And relationship with generations of accumulated knowledge.
Ancient Observation Still Matters
Traditional healers did not speak about neurotransmitters, cytokines, nicotinic receptor subtypes, autonomic signaling, mitochondrial biology, microbiology, or molecular pharmacology.
Their terminology was different.
Their bodies were the same human bodies researchers study today.
Traditional healers observed changes involving breathing, mucus, digestion, elimination, pain, alertness, fatigue, endurance, wounds, sensation, concentration, emotional release, cleansing, and recovery.
They learned that preparation mattered.
Amount mattered.
Species mattered.
The individual mattered.
Purpose mattered.
Context mattered.
Modern research gives humanity new tools for investigating those observations.
Sometimes an old explanation changes when science discovers a mechanism that earlier generations could not see.
Sometimes a traditional observation becomes the beginning of an entirely new research question.
That is one reason historical knowledge deserves to remain part of the conversation.
Tobacco’s Active Chemistry
Nicotine is tobacco's best-known compound, but tobacco contains many other biologically active substances.
Researchers have identified nicotine and related alkaloids, cembranoid diterpenes, solanesol, flavonoids, phenolic compounds, terpenes, sterols, tannins, glycosides, and numerous volatile compounds.
Tobacco extracts and isolated compounds have demonstrated antimicrobial, antifungal, insecticidal, antiparasitic, antioxidant, inflammatory, neuroactive, metabolic, cytotoxic, and antitumor activity across laboratory and animal research.
This chemistry reveals something fundamental:
Tobacco's biological story extends far beyond nicotine alone.
Why Tobacco Preparations Can Differ
The chemistry of tobacco varies.
Species, genetics, soil, climate, growing conditions, leaf maturity, plant part, harvesting, curing, storage, preparation method, concentration, and route of administration can all influence what a preparation contains and how strongly it acts.
Nicotiana tabacum and Nicotiana rustica therefore carry different chemical profiles and histories of use.
Traditional specialists learned these distinctions through generations of experience.
Modern laboratories can now measure many of those differences chemically.
Both forms of knowledge point toward the importance of preparation and respect when working with a biologically powerful plant.
Nicotinic Receptors Throughout the Body
One of the most important discoveries in nicotine science is that nicotine interacts with a communication system already built into the human body.
These receptors are called nicotinic acetylcholine receptors.
Their natural signaling molecule is acetylcholine, an important neurotransmitter produced by the body.
Nicotine can bind to several receptor subtypes and influence their activity.
Nicotinic receptors participate in functions involving attention, learning, memory, muscle activation, nerve communication, sensory processing, pain, motivation, digestion, appetite, autonomic regulation, inflammatory signaling, immune-cell activity, and communication between the brain and body.
This widespread receptor network helps explain why nicotine appears in research fields that may initially seem unrelated.
Neuroscience.
Immunology.
Gastroenterology.
Pain research.
Cognitive medicine.
Infectious-disease research.
Oncology.
They are all encountering different parts of the same biological communication system.
α7 Nicotinic Acetylcholine Receptor
One receptor receiving particular scientific attention is the α7 nicotinic acetylcholine receptor, often abbreviated α7 nAChR.
The α7 receptor occurs within the nervous system and on numerous immune and other cells.
It participates in the cholinergic anti-inflammatory pathway, a communication network through which neural and cholinergic signaling can influence inflammatory cytokines and immune activity.
This creates an extraordinary biological bridge between the nervous system and the immune system.
Researchers are investigating α7 signaling in neuroinflammation, immune regulation, inflammatory bowel disease, infection, sepsis, metabolic inflammation, neurological conditions, autoimmune processes, tumor biology, and cancer-related immune signaling.
The α7 receptor is one of the places where nervous-system communication and immune communication meet.
Inflammation and Immune Communication
Inflammation is one of the body's essential systems of defense and repair.
The cholinergic system helps researchers understand how that inflammatory response may be coordinated and regulated.
Because nicotine interacts with nicotinic acetylcholine receptors, it has become an important research tool for exploring the relationship among neural signaling, immune-cell behavior, inflammatory mediators, and recovery.
This connection has helped push nicotine research beyond its familiar historical applications and into broader questions involving immune regulation.
Viruses and Nicotinic Receptors
Nicotinic receptor biology has become an intriguing area of virology.
Researchers have investigated connections involving nicotinic signaling and viruses including herpes simplex virus, Zika virus, rabies, influenza, and SARS-CoV-2.
Laboratory research published in 2024 found that α7 nicotinic receptor activation significantly inhibited HSV-1 replication in microglial cells and influenced innate antiviral factors.
Another 2024 study found a broad effect of α7 receptor activation in limiting Zika-virus infection across multiple cell lines.
Rabies research has provided another longstanding connection between viral biology and nicotinic acetylcholine receptors.
Taken together, these areas show that nicotinic receptors can participate meaningfully in the biological relationship among viruses, cells, immune responses, and the nervous system.
Research now has an increasingly interesting question to pursue:
How does nicotinic signaling influence the relationship among a virus, the infected cell, immune communication, inflammation, and neurological function?
Different viral systems allow researchers to examine different pieces of that puzzle.
SARS-CoV-2 and Nicotinic Signaling
SARS-CoV-2 uses ACE2 as an important part of its established cellular-entry process.
Researchers have also investigated how SARS-CoV-2 proteins may interact with or influence nicotinic cholinergic signaling.
This research has included molecular modeling, receptor experiments, functional studies, cell research, and live-cell imaging.
These investigations opened a broader question about viral illness:
A virus can influence more than the mechanism it uses to enter a cell.
It can affect signaling networks throughout the body.
That possibility becomes particularly interesting when the signaling network being examined participates in cognition, smell, taste, muscle activity, autonomic function, inflammation, and immune communication.
Long COVID and Cholinergic Disruption
Long COVID brought this receptor research into an entirely new arena.
People experiencing prolonged symptoms after infection have reported combinations involving fatigue, brain fog, post-exertional malaise, dizziness, altered heart rate, disturbed sleep, muscle weakness, sensory changes, digestive concerns, altered smell or taste, pain, autonomic symptoms, and inflammatory complaints.
Researchers continue exploring several biological pathways involved in post-infectious illness.
One emerging line of research focuses specifically on disrupted nicotinic acetylcholine receptor signaling and impaired cholinergic communication.
That possibility led researchers and patients toward an intriguing question:
Could transdermal nicotine influence a cholinergic communication system that had become disrupted during or after infection?
First Published Nicotine-Patch Cases
A 2023 publication described people with persistent post-COVID symptoms who used transdermal nicotine.
The reported changes involved fatigue, brain fog, concentration, altered smell and taste, sleep, weakness, exercise tolerance, and neurological and sensory symptoms.
The author proposed that nicotine's affinity for nicotinic receptors might help restore cholinergic communication affected during post-infectious illness.
These early cases opened a new research path.
A small group of observations became a hypothesis.
That hypothesis led to additional patient experience, receptor research, imaging, and a substantially larger published dataset.
2025 Human Evidence
A 2025 Bioelectronic Medicine publication expanded this developing human evidence.
The paper examined a 231-person patient dataset involving low-dose transdermal nicotine and people reporting Long COVID, ME/CFS, overlapping Long COVID and ME/CFS, and related post-infectious conditions.
Participants included 117 people with Long COVID, 47 with Long COVID and ME/CFS, 59 with ME/CFS, and smaller groups reporting related conditions.
Across the total population, 73.5 percent reported improvement in baseline quality of life.
Within the major groups, reported improvement included:
79.5 percent among participants with Long COVID
85.1 percent among participants with Long COVID and ME/CFS
57.6 percent among participants with ME/CFS
The findings extended the human signal far beyond the first published cases and led the authors to identify low-dose transdermal nicotine as an approach deserving further controlled investigation.
Treatment Duration
The participants did not all follow one identical nicotine-patch schedule.
Average total reported patch use was approximately 17.8 days, with considerable variation among participants.
Within the dataset, longer nicotine-patch use was significantly associated with greater improvement in baseline health and function and with stronger reported remission levels.
The reported responses therefore extended well beyond a one-day or two-day exposure.
Treatment duration emerged as an important part of the observed response pattern and an important direction for continued research.
Improvement Across Smoking Histories
Another particularly revealing finding involved smoking history.
The dataset included:
158 nonsmokers
66 former smokers
7 current smokers
Reported improvement occurred among:
73.4 percent of nonsmokers
75.8 percent of former smokers
85.7 percent of current smokers
The current-smoker population was much smaller than the other groups, while the two large groups produced remarkably similar results.
Average quality-of-life improvement among nonsmokers and former smokers was also nearly identical.
Within this dataset, previous smoking history did not meaningfully predict who reported benefit.
That observation directs attention toward nicotine's broader biological activity and toward receptor systems shared across the human body.
Research pathways of particular interest include nicotinic-receptor signaling, cholinergic communication, autonomic regulation, inflammatory pathways, neurological communication, sensory processing, muscle function, and energy regulation.
The similarity between nonsmokers and former smokers strengthens the reason to investigate nicotine as a biologically active compound in its own right.
Remission Experiences
Approximately one-third of participants reported periods during nicotine-patch use or shortly afterward when their illness lifted much more completely.
Researchers described these periods as remission events.
Some participants described feeling normal and healthy.
Others described feeling better than their ordinary healthy baseline.
These particularly strong periods of relief occurred within a wider pattern of baseline improvement reported by many participants.
For people who had lived with chronic illness for months or years, those periods carried considerable meaning.
They also raise a fascinating biological question:
What changed within the body when significantly better function suddenly became possible?
The ability of a chronically impaired system to move toward normal or near-normal function gives researchers another clue about the biological reversibility of at least some symptoms.
Improvement Without Strong Reactions
The same dataset provided another useful finding.
People did not need to experience uncomfortable reactions before reporting benefit.
Among participants reporting no side effects, 80.8 percent reported improvement.
The statistical analysis did not find a meaningful relationship between experiencing side effects and experiencing improvement.
This adds an important practical insight:
A strong reaction is not a measure of how strongly a beneficial response is occurring.
A quiet biological response can still be meaningful.
Receptor Imaging and Clinical Recovery
The 2025 publication also presented a closely examined clinical case involving a woman who had experienced Long COVID symptoms for approximately three and a half years.
Her symptoms included post-exertional malaise, fatigue, brain fog, cognitive overstimulation, difficulty producing fluent speech, cold extremities, dizziness, numb fingers, and irritated or burning eyes.
Researchers used PET imaging associated with α4β2 nicotinic acetylcholine receptor binding-site availability before and after transdermal nicotine.
After treatment and after nicotine had cleared, imaging showed increased receptor-tracer availability in several tissues while her clinical condition improved substantially.
Her speech disorder resolved, and several longstanding neurological and functional symptoms were no longer detectable during follow-up.
This combination of receptor imaging, nicotine clearance, neurological recovery, and clinician-observed improvement gives the case unusual scientific interest.
It adds an objective biological layer to the developing research surrounding nicotinic receptor availability and post-infectious recovery.
Developing Receptor-Restoration Hypothesis
The possibility that nicotine may influence disrupted nicotinic signaling after infection now draws upon several converging areas of research.
Molecular modeling contributes one layer.
Functional receptor experiments contribute another.
Cell research adds another.
Clinical observations, patient surveys, receptor imaging, neurological recovery, and response patterns among people with different previous nicotine histories add human dimensions.
Together, these findings create an expanding research trail involving receptor availability, cholinergic communication, neurological function, autonomic regulation, inflammatory signaling, and post-infectious recovery.
The next chapter is understanding how these pieces connect and which biological patterns may be most responsive to this pathway.
Patient-Led Evidence
Long COVID also demonstrates the importance of patient-led discovery.
People experiencing persistent illness formed communities, compared symptoms, tracked responses, shared observations, and identified patterns while formal research was still developing.
Nicotine patches became one of several approaches explored within these communities.
A separate patient-led survey involving 175 people with Long COVID who had tried nicotine patches reported a range of experiences.
Twenty percent reported feeling more than 50 percent better.
Thirty-six percent reported improvement of up to 50 percent.
Twenty percent reported feeling the same.
Five percent reported feeling worse.
Seventeen percent were still evaluating their response.
At the time of the survey, 56 percent reported at least some improvement.
This survey was separate from the later 231-person dataset described in the 2025 publication.
Patient observation occupies its own important place in the research landscape.
It can reveal patterns, unexpected responses, symptom clusters, timing clues, and questions that deserve formal investigation.
Human observation often discovers the trail before a research institution builds the road.
Science and Human Experience
Formal studies capture the experiences of the people who participate in them.
Beyond those studies are people who learn through patient communities, work with independent practitioners, explore an approach privately, improve without reporting it publicly, leave support communities after recovering, or never reach a specialty clinic or research program.
The complete number of people who have independently explored transdermal nicotine for post-infectious illness is unknown.
Formal research remains essential for measuring patterns, refining mechanisms, determining treatment protocols, and identifying who responds best.
Human experience remains one of the places where those research questions originate.
Why Responses May Differ
Long COVID appears to involve multiple overlapping biological patterns.
Different individuals may show different combinations involving cholinergic signaling, persistent viral material, immune regulation, autonomic function, circulation, cellular energy production, reactivated infections, mast-cell activity, neurological changes, or lasting tissue effects.
Differences in receptor subtype, receptor availability, nicotine metabolism, transdermal absorption, genetics, medications, health history, and stage of illness may also influence response.
Variation itself can become useful information.
It can help researchers move from asking “Does this have an effect?” toward the more precise questions of “Who responds?” “Which biological pattern responds?” and “Why?”
Dr. Bryan Ardis and the Modern Reconsideration of Nicotine
Dr. Bryan Ardis, D.C., has become an important modern voice in the renewed conversation surrounding tobacco, nicotine, nicotinic acetylcholine receptors, and the potential applications of controlled nicotine preparations.
Nicotine research itself reaches back many decades.
Researchers had already investigated nicotinic receptors, cognition, ulcerative colitis, neurological disease, inflammation, pharmacology, and other therapeutic possibilities before his public work.
Dr. Ardis's contribution has been different.
He has helped bring older medical literature, overlooked scientific research, tobacco's medicinal history, receptor biology, and patient observations back before a much larger modern audience.
Nicotine has become a substantial subject within his educational work.
His official platform has devoted dedicated presentations and programs to nicotine, including The Other “N” Word, receptor biology, cognitive questions, historical tobacco medicine, and his interpretations of nicotine's possible therapeutic applications.
Through presentations, interviews, educational programs, and public discussions, Dr. Ardis has encouraged people to investigate tobacco's historical medicinal use, older medical literature, nicotine as a naturally occurring plant alkaloid, nicotinic acetylcholine receptors, nicotine gum and patches, neurological research, inflammatory signaling, pain, smell and taste, COVID, Long COVID, post-infectious illness, and patient experiences.
One of the valuable qualities of his work is his willingness to look backward as well as forward.
Some of the medical literature he highlights is modern.
Some is decades old.
Some reaches several centuries into the documented history of tobacco as medicine.
Older medical literature can preserve important observations, forgotten treatment traditions, hypotheses, and research paths.
Modern science has better tools for examining those observations, but the original observation still matters.
Dr. Ardis has helped reconnect some of these historical threads with modern understanding of nicotinic acetylcholine receptors.
That connection is particularly interesting because receptor biology now provides a language earlier physicians and traditional healers did not possess.
Researchers can now examine how nicotinic signaling participates in attention, memory, movement, digestion, autonomic regulation, immune communication, inflammation, sensory processing, and neurological function.
Dr. Ardis has also played a meaningful role in bringing nicotine gum and transdermal nicotine patches into contemporary public discussion as controlled nicotine preparations and in drawing attention to nicotine-patch experiences surrounding Long COVID and other post-infectious concerns.
His presentations often move beyond conclusions presently established by clinical research, which makes it especially useful to follow the research trails he highlights back to their original sources.
That process can enrich the conversation.
A public educator raises the question.
Researchers provide studies.
Patients provide observations.
Historical medicine provides earlier clues.
Modern laboratories investigate mechanisms.
One need not erase another.
Dr. Ardis's role in encouraging people to revisit nicotine, nicotinic receptors, historical tobacco medicine, and overlooked literature deserves meaningful recognition on this page.
He did not begin the scientific story of nicotine.
He has helped bring an important and frequently overlooked part of that story back into the light.
Nicotine and the Brain
The relationship between nicotine and the brain represents one of the longest-running areas of nicotine research.
Nicotinic acetylcholine receptors participate in networks involving attention, vigilance, learning, memory, sensory filtering, motivation, movement, dopamine signaling, and neuroplasticity.
Controlled studies have therefore investigated nicotine across a wide range of cognitive and neurological questions.
Attention and Mental Performance
Research has found measurable nicotine effects on aspects of attention and cognition.
A meta-analysis of human studies found significant effects across several performance domains, including attention-related measures.
The pattern is particularly interesting because baseline cognitive performance can influence response.
Nicotinic signaling appears to help regulate how the brain detects information, directs attention, filters stimuli, and maintains focus.
Mild Cognitive Impairment
Transdermal nicotine has been studied in nonsmoking adults with mild cognitive impairment.
A six-month randomized clinical trial found improvement in several measures of cognitive test performance among participants receiving transdermal nicotine.
This human trial provides another piece of evidence connecting nicotinic receptor signaling with attention, memory-related processing, and cognitive function.
Parkinson’s, Alzheimer’s, and Neurodegenerative Research
Nicotine and nicotinic receptors have been investigated for decades in Parkinson's disease, Alzheimer's disease, and other neurological conditions.
Laboratory studies, epidemiological observations, receptor research, dopamine biology, and neuroprotective mechanisms have all contributed to this field.
Modern clinical studies continue refining which aspects of nicotinic signaling may be therapeutically useful and which approaches need different targets, compounds, delivery systems, or receptor selectivity.
This is one of the clearest examples of why older research still matters.
An early observation may identify the biological neighborhood even when later science is still trying to find the exact address.
ADHD, Tourette Syndrome, and Neurological Signaling
Nicotine has also been investigated in smaller human studies involving ADHD and Tourette syndrome.
A controlled study in adults with ADHD reported nicotine-related improvement in clinician-rated global measures, including findings among nonsmokers.
Research of this kind adds to the larger understanding that nicotinic receptors participate in attention, sensory filtering, movement, motivation, and behavioral regulation.
Ulcerative Colitis
Ulcerative colitis has one of the most substantial histories of medicinal nicotine research outside its established pharmaceutical use.
Controlled human trials found that transdermal nicotine could improve active ulcerative colitis in some patients. One randomized trial reported improved symptoms when transdermal nicotine was added to conventional maintenance therapy.
Systematic-review evidence also found transdermal nicotine more effective than placebo for induction of remission in active ulcerative colitis.
This research demonstrates measurable human biological effects of nicotine involving intestinal inflammation and cholinergic communication.
Nicotine Gum
Nicotine gum provides measured nicotine absorbed primarily through tissues in the mouth.
Its delivery is shorter and more adjustable than a transdermal patch.
The labeled chew-and-park technique allows nicotine to move through the oral lining over time.
This makes gum particularly useful for understanding one of the most important principles in nicotine pharmacology:
Delivery matters.
The same compound can behave differently depending upon how quickly it enters the body, how high the concentration rises, how long exposure continues, and how frequently another amount is used.
Nicotine Patches
Nicotine patches provide gradual transdermal delivery over many hours.
This creates a steadier exposure profile than nicotine gum.
Transdermal nicotine has been investigated in research involving cognition, attention, ulcerative colitis, neurological conditions, inflammatory signaling, pain, Long COVID, and post-infectious conditions.
A systematic review identified 33 studies involving transdermal nicotine exposure lasting more than 48 hours in nonsmokers, with considerable variation in amounts, escalation schedules, and treatment duration.
This broad research history provides a substantial foundation for understanding transdermal nicotine outside one narrow use.
Beginning Gently
People without previous nicotine exposure may respond to comparatively small amounts.
Clinical research has frequently introduced transdermal nicotine progressively rather than beginning immediately at the highest study amount.
Dr. Ardis and patient communities have also emphasized reducing exposure when someone finds an initial amount too strong.
The principle is simple:
More is not automatically more medicinal.
A quiet response can still be biologically meaningful.
Medicinal Nicotine and Dependence
Nicotine dependence is strongly influenced by the way nicotine is delivered.
Speed, amount, frequency, duration, previous exposure, behavioral conditioning, and individual biology all influence reinforcement.
Transdermal nicotine provides gradual delivery.
A systematic review involving transdermal nicotine in nonsmokers found no reported withdrawal symptoms or addictive behavior in the reviewed studies, while also noting that formal long-term assessment of future dependence was limited.
Nicotine gum has its own delivery profile and therefore deserves separate consideration from transdermal exposure.
This creates a more useful question than treating every exposure identically:
How do delivery method, speed, amount, frequency, and individual biology shape the human relationship with nicotine?
That question opens the door to a much more precise understanding.
Traditional Tobacco and Dependence
Traditional tobacco practices also existed within very different patterns of use.
Some were occasional.
Some ceremonial.
Some medicinal.
Some seasonal.
Some specialist-guided.
Some governed by cultural boundaries and connected to a particular prayer, healing purpose, or ceremony.
Purpose, preparation, amount, frequency, delivery method, cultural setting, and relationship with the plant can all influence how a psychoactive plant is experienced.
Traditional tobacco medicine, ceremonial tobacco, nicotine gum, and transdermal nicotine belong to distinct contexts.
Digestion, Purging, and Cleansing
Tobacco preparations have traditionally been associated with digestive stimulation, elimination, mucus clearing, purging, and cleansing.
Strong preparations can influence salivation, intestinal activity, expectoration, sweating, nausea, and vomiting.
Within some Amazonian healing systems, these physical events exist within a larger concept of purification involving dietary discipline, emotional release, prayer, rest, observation, spiritual reflection, and restoration of balance.
The word detoxification therefore carries different meanings within different healing traditions.
Contemporary physiology generally applies the concept to measurable biological transformation and elimination.
Traditional healing systems may understand cleansing more broadly, incorporating physical, emotional, mental, relational, and spiritual dimensions.
Understanding both requires recognizing the framework in which each is being used.
Amazonian Tobacco Medicine
Traditional Amazonian tobacco medicine continues to attract modern scholarly attention.
Nicotiana rustica may occupy a central role within specialist healing practices involving patient selection, preparation, dietary discipline, observation, ceremony, purging, rest, spiritual practice, and integration.
Modern observational research has begun studying tobacco therapy inside that traditional setting rather than reducing the practice to nicotine alone.
This matters because traditional medicine often includes far more than a molecule.
The practitioner matters.
Preparation matters.
Environment matters.
Diet may matter.
Ceremony matters.
Observation matters.
Relationship matters.
A medicinal system is sometimes larger than the chemical compound sitting at its center.
Respiratory Clearing
Historical tobacco practices included approaches associated with mucus, congestion, cough, respiratory heaviness, and expectoration.
Traditional preparations could stimulate salivation, coughing, mucus movement, expectoration, and other autonomic responses.
These observations provide another area where historical medicine and modern physiology can meet.
Ancient practitioners observed an effect.
Modern researchers can ask which receptors, secretory pathways, neural signals, and smooth-muscle responses may help explain it.
Pain and Physical Discomfort
Historical medical records describe tobacco preparations for toothache, headache, rheumatic discomfort, painful joints, sprains, wounds, and other painful conditions.
Modern research provides an intriguing biological bridge.
Nicotinic acetylcholine receptors participate in pain signaling within the brain, spinal cord, peripheral nervous system, and inflammatory pathways.
Pain research involving nicotinic receptors remains active because different receptor subtypes may influence different elements of pain perception and neuroinflammation.
Wounds, Burns, and External Preparations
Tobacco leaves, powders, washes, and poultices were historically used for wounds, sores, burns, swollen areas, boils, insect bites, sprains, and painful joints.
Laboratory findings involving antimicrobial and inflammatory activity among tobacco compounds provide possible biological context for some of these traditional observations.
The historical record preserves an important clue:
Traditional healers recognized that tobacco's activity could extend beyond ingestion and into topical preparation.
Parasites, Worms, Lice, and Insects
Nicotine forms part of tobacco's natural defense system.
It disrupts neural signaling in many organisms that would otherwise feed upon the plant.
This helps explain tobacco's long association with lice, mites, agricultural insects, intestinal worms, and other pests and parasites.
Traditional antiparasitic use and experimental biological activity both belong to tobacco's history.
This area represents another meeting place among ethnomedicine, plant chemistry, parasitology, and pharmacology.
Tobacco and the Nightshade Family
Tobacco belongs to the Solanaceae, commonly known as the nightshade family.
The family also includes tomatoes, tomatillos, eggplant, potatoes, peppers, goji berries, ground cherries, cape gooseberries, and numerous other plants.
Ashwagandha also belongs to the Solanaceae.
Trace nicotine has been measured naturally in several nightshade foods, including tomatoes, potatoes, eggplant, and peppers.
These amounts are tiny compared with measured pharmaceutical nicotine preparations.
But the botanical point is important.
Nicotine is a naturally occurring plant alkaloid.
The tomato offers a botanical whisper. Gum and patches provide a measured pharmacological message.
Solanesol and Pharmaceutical Production
Solanesol is another valuable compound found abundantly in tobacco leaves.
It can serve as a starting material in pharmaceutical production, including compounds related to coenzyme Q10 and vitamin K.
Solanesol and its derivatives have also attracted research involving antioxidant, inflammatory, neurological, mitochondrial, and pharmaceutical applications.
This represents another form of medicinal value.
The plant itself can become a source of useful molecular building blocks.
Tobacco Cembranoids
Tobacco contains diterpenes known as cembranoids.
Researchers have investigated tobacco cembranoids for antimicrobial, insecticidal, inflammatory, neuroprotective, and anticancer activity.
Cancer research has explored their effects upon cell proliferation, cell migration, colony formation, invasion, recurrence-related pathways, and tumor-associated immune signaling.
Cembranoids are another reminder that the tobacco plant contains a much larger chemical library than nicotine alone.
Three Cancer Pathways Emerging From Tobacco Research
Tobacco's relationship with cancer science now extends across three remarkably different areas.
Natural tobacco compounds are being investigated as anticancer molecular leads.
Nicotinic receptor subtypes are being studied as possible precision cancer targets.
And Nicotiana plants are being used as living biological factories capable of producing experimental antibodies, immunotherapies, and personalized cancer vaccines.
Each represents a different scientific pathway.
Together they reveal the remarkable breadth of modern tobacco research.
Tobacco Cembranoids and Cancer Research
Cembranoid diterpenes isolated from Nicotiana tabacum have drawn serious interest in experimental cancer research.
Two particularly studied compounds are α-cembrenediol and β-cembrenediol.
Researchers have examined these molecules in connection with cancer-cell proliferation, programmed cell death, migration, colony formation, tumor invasion, angiogenic signaling, recurrence, metastasis, and tumor-associated immune pathways.
β-cembrenediol has received particular attention in prostate-cancer models.
Experimental work has reported effects involving cancer-cell migration, colony formation, recurrence, metastasis, PSA, and pathways associated with tumor immune escape.
These natural molecules can serve as research leads and molecular scaffolds, giving scientists structures that can be studied, refined, and potentially developed into more selective compounds.
Many medicines have begun this way.
A plant reveals a molecule.
Researchers uncover what it can do.
Science learns how to build from the clue.
Nicotinic Receptors as Cancer Targets
Nicotinic acetylcholine receptors themselves have also entered cancer research.
Different receptor subtypes have been studied in lung, breast, prostate, gastric, head-and-neck, liver, colon, bladder, and other cancers.
Researchers are examining their involvement in cell proliferation, survival, angiogenesis, migration, invasion, metastasis, treatment resistance, and tumor immune communication.
This reveals the remarkable complexity of nicotinic receptor biology.
A receptor pathway can play different roles depending upon the receptor subtype, tissue, disease process, and biological environment.
That precision is exactly what makes receptor-targeted medicine such an important area of modern research.
Tobacco Plants as Living Medicine Factories
Perhaps the most unexpected modern chapter involves using tobacco-family plants to manufacture medicines.
Nicotiana benthamiana has become an important platform in molecular farming.
Scientists can introduce genetic instructions into plant cells and temporarily transform the leaves into biological manufacturing systems.
These plants can produce monoclonal antibodies, vaccine proteins, enzymes, diagnostic proteins, experimental therapeutic molecules, immune-checkpoint antibodies, multi-target antibodies, and personalized cancer-vaccine material.
The desired molecule is then extracted and purified.
The plant functions as a living pharmaceutical workshop.
Plant-Grown Cancer Immunotherapies
Researchers have used Nicotiana plants to produce experimental antibodies involving important cancer-immunotherapy targets such as CTLA-4, PD-1, and PD-L1.
Plant-expression systems have also produced sophisticated therapeutic antibodies for laboratory and preclinical evaluation.
The significance is remarkable.
A plant cell can receive genetic instructions and assemble a highly complex biological protein with medically useful properties.
The leaf becomes part of the manufacturing process.
Personalized Cancer Vaccines
Plant molecular farming has already reached human cancer research.
Plant-made conjugate vaccines designed for people with follicular B-cell lymphoma have undergone Phase I safety and immunogenicity study.
These personalized approaches use molecular information associated with an individual's tumor to create targeted vaccine material.
The concept represents an extraordinary meeting point between botanical biology and personalized oncology.
A plant once carried within ancient healing traditions can now be given genetic instructions connected with an individual person's cancer and help manufacture an experimental personalized medicine.
Understanding the Evidence
The tobacco and nicotine story contains several different evidence streams, and each deserves to be understood for what it contributes.
Established medical use includes standardized pharmaceutical nicotine preparations with decades of clinical experience.
Human clinical research includes nicotine studies involving ulcerative colitis, cognition, attention, neurological questions, and other conditions. The six-month mild-cognitive-impairment trial and controlled ulcerative-colitis studies demonstrate measurable effects in humans.
Developing human research includes the Long COVID case reports, 231-person patient dataset, receptor imaging, and patient-led observations that have created a substantial signal for further investigation.
Laboratory and animal research allows scientists to investigate receptors, viruses, inflammation, neuroprotection, parasites, cancer-cell behavior, molecular targets, and mechanisms that may eventually guide human research.
Historical medical literature preserves earlier observations and therapeutic questions.
Traditional and Indigenous knowledge preserves generations of experience involving preparation, ceremonial relationship, physical effects, spiritual practice, and specialist use.
Patient experience can reveal emerging patterns before formal trials have fully developed.
The strength of the subject comes from allowing these evidence streams to remain visible rather than asking one of them to erase the others.
Each asks a different kind of question.
Together they create a fuller picture.
How to Use It Wisely
Tobacco is a powerful plant, and its strength is part of why many traditional systems surrounded it with knowledge, preparation, boundaries, and respect.
Concentrated historical preparations belong to the historical and ethnomedical record and to specialist traditions with knowledge of species, preparation, amount, patient selection, and response.
Traditional Amazonian tobacco medicine belongs to a larger healing system involving practitioner knowledge, preparation, diet, observation, supervision, ceremony, and cultural understanding.
Nicotine gum and nicotine patches provide standardized forms of controlled nicotine exposure, yet individual response can vary according to amount, previous exposure, metabolism, medication use, cardiovascular health, receptor sensitivity, and other personal factors.
Research protocols also vary according to the question being studied.
The amount used in one study therefore belongs first to that study.
Beginning gently allows the body's response to be observed.
More is not automatically more medicinal.
A powerful compound deserves a thoughtful relationship with dose.
Additional medical guidance is especially valuable during pregnancy or breastfeeding, with significant cardiovascular or heart-rhythm conditions, with medication interactions, or when a person experiences concerning symptoms during nicotine exposure.
Respect for tobacco and nicotine includes respect for preparation, amount, context, and the individual body.
Tobacco’s Larger Story
Tobacco has carried many identities across human history.
Sacred offering.
Traditional medicine.
Botanical remedy.
Source of nicotine.
Pharmaceutical raw material.
Receptor research tool.
Source of experimental anticancer compounds.
Living biological factory.
Ancient healers observed tobacco through generations of human experience.
Historical physicians preserved observations in medical texts.
Modern scientists discovered nicotinic acetylcholine receptors and began mapping an extraordinary communication system running through the brain, nervous system, immune system, muscles, digestive system, and autonomic nervous system.
Patients experiencing post-infectious illness added another layer of observation.
Researchers began investigating cholinergic disruption, receptor availability, and transdermal nicotine.
Dr. Bryan Ardis helped bring forgotten nicotine literature, receptor research, and tobacco's older medicinal history back before a much wider public audience.
Cancer researchers followed tobacco molecules into tumor biology.
Biotechnologists went still further and transformed Nicotiana leaves into living factories capable of manufacturing sophisticated biological medicines.
These stories do not have to compete with one another.
They belong to different chapters of the same extraordinary plant.
Some discoveries are centuries old.
Some emerged decades ago.
Some were published within the last few years.
Some exist in laboratories today.
Some began with traditional healers.
Some began with patients.
Some began when a researcher looked at an old question through a new instrument.
The responsible approach is curiosity joined with evidence.
Preserve what was observed.
Examine what was discovered.
Honor the people who carried the knowledge.
Read the older literature.
Follow the emerging research.
Let each form of evidence speak from its proper place.
And remain willing to learn more.
Tobacco's complete medicinal and scientific story is still being written.
Questions and Answers
What is the focus of this tobacco and nicotine page?
This page explores the tobacco plant, Nicotiana tabacum, Nicotiana rustica, traditional and ceremonial preparations, naturally occurring tobacco compounds, nicotinic acetylcholine receptors, nicotine gum, nicotine patches, medicinal nicotine research, cancer-related tobacco compounds, receptor biology, and tobacco plants used in biotechnology.
Is nicotine the same thing as tobacco?
Nicotine is one naturally occurring alkaloid within tobacco.
The plant also contains cembranoids, solanesol, flavonoids, phenolic compounds, terpenes, sterols, and numerous other biologically active substances.
What are nicotinic acetylcholine receptors?
Nicotinic acetylcholine receptors are receptors naturally present throughout the nervous system and numerous other tissues and cells.
Their natural signaling molecule is acetylcholine.
Nicotine can interact with several receptor subtypes, helping explain its relevance to attention, memory, movement, digestion, autonomic regulation, inflammation, immunity, pain, and sensory processing.
Why is the α7 nicotinic receptor important?
The α7 nicotinic acetylcholine receptor is heavily involved in research examining communication between the nervous and immune systems.
It is particularly important in research surrounding the cholinergic anti-inflammatory pathway, neuroinflammation, infection, immune regulation, neurological conditions, and cancer biology.
Why are nicotinic receptors being studied in viral research?
Experimental research has demonstrated that nicotinic receptor signaling can influence viral infection and cellular antiviral responses in several models.
Recent studies involving HSV-1 and Zika provide examples of α7 receptor activation influencing viral replication and antiviral defense.
The field is helping researchers understand how neural and immune signaling intersect during infection.
Is nicotine being researched for Long COVID?
Yes.
Published clinical cases, a 231-person patient dataset, patient-led observations, receptor research, and PET imaging have all contributed to interest in transdermal nicotine and cholinergic signaling in Long COVID.
Did people without previous smoking histories report improvement?
Yes.
Within the 231-person dataset, reported improvement occurred among nonsmokers as well as former smokers.
The similarity between the two large groups is one of the more interesting findings and supports continued investigation of nicotine's broader receptor-related biological activity.
How long did participants use nicotine patches?
Average reported use in the 231-person dataset was approximately 17.8 days, with substantial variation.
Longer use was significantly associated with greater reported baseline improvement and stronger remission experiences within the dataset.
Did people need side effects before improving?
No.
Improvement was also reported among participants who experienced no significant side effects.
A strong reaction was not required for benefit to be observed in the patient data.
Why does patient-led evidence matter?
Patients can recognize patterns before large research programs have fully developed.
Their observations can reveal unexpected responses, symptom clusters, timing patterns, and questions worthy of formal investigation.
Patient experience has played an especially important role in the history of Long COVID.
Who is Dr. Bryan Ardis?
Dr. Bryan Ardis, D.C., is a health educator and public advocate who has helped bring renewed attention to tobacco's medicinal history, older nicotine literature, nicotinic acetylcholine receptors, nicotine gum and patches, neurological research, and post-infectious health questions.
Nicotine has become a significant subject within his educational work, including dedicated presentations examining nicotine history, receptor biology, and potential therapeutic applications.
His work has encouraged a broader modern audience to revisit research and historical material that many people had never encountered.
Why does older medical literature still matter?
Older literature preserves observations, treatment traditions, forgotten hypotheses, and research questions.
Modern scientific tools allow those earlier observations to be tested and interpreted in new ways.
The date of a medical observation tells us when it was recorded.
The quality of the observation and the evidence surrounding it tell us how much it can teach us.
Was tobacco historically used as medicine?
Yes.
Historical and ethnomedical records document numerous medicinal and ceremonial uses of tobacco.
These records form an important part of tobacco's botanical and medical history.
Has nicotine been studied for cognitive function?
Yes.
Nicotine and nicotinic acetylcholine receptors have been studied extensively in relation to attention and cognition.
A six-month randomized trial in nonsmoking adults with mild cognitive impairment reported improvement in several measures of cognitive test performance.
Has nicotine been studied for ulcerative colitis?
Yes.
Controlled human trials have found clinically measurable effects of transdermal nicotine in active ulcerative colitis, and systematic review evidence found greater induction of remission than placebo.
Are nicotine gum and nicotine patches the same?
They provide different nicotine-delivery patterns.
Gum produces a shorter, more adjustable exposure through oral absorption.
Patches deliver nicotine gradually through the skin over many hours.
Those differences in speed and duration matter biologically.
What does research say about transdermal nicotine and dependence in nicotine-naïve people?
A systematic review of transdermal nicotine studies involving nonsmokers found no reported withdrawal symptoms or addictive behavior in the reviewed research, while noting that formal long-term dependence assessment was limited.
The findings reinforce the importance of delivery method when discussing nicotine's reinforcing properties.
Can tobacco affect parasites and insects?
Tobacco and nicotine possess biological activity against various insects and other organisms, helping explain their long history in agricultural and traditional antiparasitic applications.
The subject remains an interesting intersection of plant defense chemistry, ethnomedicine, parasitology, and pharmacology.
Is nicotine naturally present in foods?
Trace nicotine naturally occurs in several plants within the nightshade family, including tomatoes, potatoes, eggplant, and peppers.
The quantities are much smaller than those found in measured pharmaceutical nicotine preparations.
Does tobacco contain compounds being researched for cancer?
Yes.
Tobacco cembranoids are being investigated as experimental anticancer molecular leads, while selected nicotinic receptor subtypes are being studied as potential targets within cancer biology.
Can tobacco-family plants manufacture medicines?
Yes.
Nicotiana species can serve as molecular-farming platforms.
Scientists introduce genetic instructions into plant cells, allowing the plants to manufacture complex proteins that can later be extracted and purified.
Have plant-made cancer vaccines reached human research?
Yes.
Plant-made targeted vaccines for follicular B-cell lymphoma have undergone Phase I human study, demonstrating the ability of plant molecular farming to enter personalized cancer research.
What is the larger lesson from tobacco and nicotine research?
Tobacco is far more complex than one compound or one historical chapter.
Its story encompasses traditional medicine, sacred practice, historical medical literature, plant chemistry, receptor biology, neuroscience, immunology, infectious-disease research, oncology, and biotechnology.
Understanding that story means allowing ancient observation, modern science, patient experience, and emerging research to be examined together without forcing them into one narrow narrative.
There is still much to learn.
And that is exactly why the story remains worth exploring.
Wellness Pathways ↑
Explore more gentle, grounded wellness pages in the Wellness Pathways ↑